Pfizer is undervalued as markets fixate on its patent cliff, overlooking strong cash flows, pipeline upside, and a 7% yield.

Intercontinental Exchange is well-positioned for growth in FY25 with strong trading volumes, innovation and strategic M&A.

Vanguard Short-Term Treasury Index Fund ETF Shares reduces portfolio risk, enhances liquidity, and stabilizes returns. Learn ...

Varonis excels in data security with SaaS growth, but high valuation and unclear margins pose risks. Read here for an ...

VOOV provides defensive, value-driven exposure with lower tech weight, appealing amid inflation risks and slower growth. Find ...

Nike remains resilient amid tariffs, weak demand, and supply chain risks, supported by strong financials and brand value. See ...

Japan’s headline inflation moderated a bit to 3.5% YoY in May (vs 3.6% in April, 3.5% market consensus), in line with market ...

Pampa Energía capitalizes on Argentina's stabilization, driving growth in LNG, shale oil and renewables. See more on PAM ...

Global private equity buyouts of corporate units (AKA carve-outs) have increased as corporations focus on balance sheets in ...

Five of the ten lowest-priced S&P 500 Dividend Aristocrats are currently attractive buys. Learn strategies for maximizing ...

First quarter 2025 production reports of the Mine Safety and Health Administration (MSHA) indicate quarter-end production at ...

Palantir (PLTR) is a top investment in 2025, thriving on global instability with AI-powered defense solutions and robust ...